Ghrelin: Much more than a hunger hormone

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 6, 2013, Pages 619-624

  Pradhan, Geetali ^a   Samson, Susan L ^b   Sun, Yuxiang ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

bone; ghrelin; glucose and energy homeostasis; growth hormone secretagogue receptor; heart and muscle

Indexed keywords

ANAMORELIN; GHRELIN; GHRELIN RECEPTOR; GLUCOSE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; PROTEIN KINASE B; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANOREXIA NERVOSA; APPETITE; BODY FAT; BONE METABOLISM; CACHEXIA; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY EXPENDITURE; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLYCOGENOLYSIS; GROWTH HORMONE RELEASE; HEART INFARCTION; HEART PROTECTION; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PROGNOSIS; REGULATORY MECHANISM; REVIEW; SARCOPENIA; SIGNAL TRANSDUCTION; SURVIVAL; SYMPATHETIC NERVE; THERMOGENESIS;

ANIMALIA;

ANIMALS; APPETITE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY METABOLISM; GHRELIN; GLUCOSE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; HUNGER; INSULIN; MODELS, ANIMAL; MUSCULAR ATROPHY; MYOCYTES, CARDIAC; OBESITY; OSTEOBLASTS; OSTEOGENESIS;

EID: 84886376211     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328365b9be     Document Type: Review

References (52)

1. Sato T, Nakamura Y, Shiimura Y, et al. Structure, regulation and function of ghrelin. J Biochem 2012; 151:119-128.
2. Kirchner H, Heppner KM, Tschop MH. The role of ghrelin in the control of energy balance. Handb Exp Pharmacol 2012; 161-184.
3. Varela L, Vazquez MJ, Cordido F, et al. Ghrelin and lipid metabolism: key partners in energy balance. J Mol Endocrinol 2011; 46:R43-R63.
4. Andrews ZB, Erion DM, Beiler R, et al. Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 2010; 151:2078-2086.
5. Perez-Tilve D, Heppner K, Kirchner H, et al. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 2011; 25:2814-2822.
6. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3:379-386.
7. Lin L, Saha PK, Ma X, et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011; 10:996-1010.
8. Choi HJ, Ki KH, Yang JY, et al. Chronic central administration of ghrelin increases bone mass through a mechanism independent of appetite regulation. PLoS One 2013; 8:e65505.
9. Ma X, Lin Y, Lin L, et al. Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice. Am J Physiol Endocrinol Metab 2012; 303:E422-E431.
10. Li RL, Sherbet DP, Elsbernd BL, et al. Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids. J Biol Chem 2012; 287:17942-17950.
11. Chacko SK, Haymond MW, Sun Y. Effect of ghrelin on glucose regulation in mice. Am J Physiol Endocrinol Metab 2012; 302:E1055-E1062.
12. Zakhari JS, Zorrilla EP, Zhou B, et al. Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice. Mol Pharm 2012; 9:281-289.
13. Mao Y, Tokudome T, Otani K, et al. Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves. Endocrinology 2012; 153:3426-3434.
14. Mao Y, Tokudome T, Otani K, et al. Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice. Endocrinology 2013; 154:1854-1863.
15. Cao Y, Tang J, Yang T, et al. Cardioprotective effect of ghrelin in cardiopulmonary bypass involves a reduction in inflammatory response. PLoS One 2013; 8:e55021.
16. Yuan MJ, He H, Hu HY, et al. Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model. Regul Pept 2012; 179:39-42.
17. Sugiyama M, Yamaki A, Furuya M, et al. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Regul Pept 2012; 178:21-28.
18. Porporato PE, Filigheddu N, Reano S, et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 2013; 123:611-622.
19. van der Velde M, van der Eerden BC, Sun Y, et al. An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 2012; 153:3593-3602.
20. McLarnon A. Metabolism: age-dependent balance of leptin and ghrelin regulates bone metabolism. Nat Rev Endocrinol 2012; 8:504.
21. Verhulst PJ, Depoortere I. Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol 2012; 18:3183-3195.
22. Park S, Jiang H, Zhang H, Smith RG. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci U S A 2012; 109:19003-19008.
23. Senniappan S, Arya VB, Hussain K. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocrinol Metab 2013; 17:19-30.
24. Zhao TJ, Liang G, Li RL, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci U S A 2010; 107:7467-7472.
25. Yi CX, Heppner KM, Kirchner H, et al. The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One 2012; 7:e32100.
26. Wang Q, Liang X, Wang S. Intra-islet glucagon secretion and action in the regulation of glucose homeostasis. Front Physiol 2012; 3:485.
27. Cryer PE. Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 2012; 153:1039-1048.
28. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350:2272-2279.
29. Chen W, Hoo RL, Konishi M, et al. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem 2011; 286:34559-34566.
30. Chuang JC, Sakata I, Kohno D, et al. Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Mol Endocrinol 2011; 25:1600-1611.
31. Gagnon J, Anini Y. Glucagon stimulates ghrelin secretion through the activation of MAPK and EPAC and potentiates the effect of norepinephrine. Endocrinology 2013; 154:666-674.
32. Viollet B, Guigas B, Sanz Garcia N, et al. Cellular and molecular mechanisms of metformin: an overview. Clin Sci 2012; 122:253-270.
33. Gagnon J, Sheppard E, Anini Y. Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells. Diabetes Obesity Metab 2013; 15:276-279.
34. Scott MM, Perello M, Chuang JC, et al. Hindbrain ghrelin receptor signaling is sufficient to maintain fasting glucose. PLoS One 2012; 7:e44089.
35. Chuang JC, Perello M, Sakata I, et al. Ghrelin mediates stress-induced foodreward behavior in mice. J Clin Invest 2011; 121:2684-2692.
36. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85:495-522.
37. Wiedmer P, Nogueiras R, Broglio F, et al. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3:705-712.
38. Sun Y. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 2004; 101:4679-4684.
39. Nedergaard J, Cannon B. The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab 2010; 11:268-2672.
40. Townsend K, Tseng YH. Brown adipose tissue: recent insights into development, metabolic function and therapeutic potential. Adipocyte 2012; 1:13-24.
41. Saito M. Brown adipose tissue as a regulator of energy expenditure and body fat in humans. Diabetes Metab J 2013; 37:22-29.
42. Jardine DL, Charles CJ, Ashton RK, et al. Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J Physiol 2005; 565:325-333.
43. Khazaei M, Tahergorabi Z. Systemic ghrelin administration alters serum biomarkers of angiogenesis in diet-induced obese mice. Int J Peptides 2013; 2013: 249565.
44. Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007; 18:986-994.
45. Delhanty PJ, van der Eerden BC, van Leeuwen JP. Ghrelin and bone. Biofactors 2013. [Epub ahead of print]. doi: 10.1002/biof.1120.
46. Shah M, Kola B, Bataveljic A, et al. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 2010; 47:309-319.
47. Costa JL, Naot D, Lin JM, et al. Ghrelin is an osteoblast mitogen and increases osteoclastic bone resorption in vitro. Int J Peptides 2011; 2011: 605193.
48. Napoli N, Pedone C, Pozzilli P, et al. Effect of ghrelin on bone mass density: the InChianti study. Bone 2011; 49:257-263.
49. Hotta M, Ohwada R, Akamizu T, et al. Therapeutic potential of ghrelin in restricting-type anorexia nervosa. Meth Enzymol 2012; 514:381-398.
50. Miki K, Maekura R, Nagaya N, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One 2012; 7:e35708.
51. Anker MS, von Haehling S, Springer J, et al. Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci 2013; 9:166-171.
52. Yagi T, Ueda H, Amitani H, et al. The role of ghrelin, salivary secretions, and dental care in eating disorders. Nutrients 2012; 4:967-989.